01548 金斯瑞生物科技
按盘价 
18.660 +0.060 (+0.323%) | 2022/12 - 末期 美元() | 2021/12 美元() | 2020/12 美元() | 2019/12 美元() | 2018/12 美元() | |
| 经营活动之现金流量 | (120,292,000) | (136,790,000) | (151,093,000) | (29,955,000) | 307,659,000 |
| 投资活动之现金流量 | (443,296,000) | (212,548,000) | (100,166,000) | (208,633,000) | (193,962,000) |
| 融资活动之现金流量 | 419,317,000 | 902,141,000 | 624,203,000 | (2,778,000) | 257,322,000 |
| 现金及等同现金之增加/(减少) | (144,271,000) | 552,803,000 | 372,944,000 | (241,366,000) | 371,019,000 |
| 期初之现金及现金等价物 | 1,180,971,000 | 629,058,000 | 252,397,000 | 494,558,000 | 123,857,000 |
| 汇率变动之影响 | (12,701,000) | (890,000) | 3,717,000 | (795,000) | (318,000) |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | 1,023,999,000 | 1,180,971,000 | 629,058,000 | 252,397,000 | 494,558,000 |
| 备注： | 实时报价更新时间为09/06/2023 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | USD -226,851,000 |
| 增长率 | -36.760% |
| 每股盈利/(亏损) | USD -0.108 |
| 每股账面资产净值 ($) | USD 0.478 |